Companies / ABT vs JNJ
ABT vs JNJ: Abbott Laboratories and Johnson & Johnson
Abbott Laboratories (ABT) reported $44.3B in revenue against a 14.7% net margin, while Johnson & Johnson (JNJ) reported $94.2B at a 28.5% net margin, most recently.
| Metric | ABT | JNJ |
|---|---|---|
| Revenue | $44.3B | $94.2B |
| Net Income | $6.5B | $26.8B |
| Gross Margin | 56.4% | 67.9% |
| Operating Margin | 18.2% | — |
| EPS (Diluted) | $3.72 | $11.03 |
| Free Cash Flow | $7.4B | $19.7B |
| Total Debt | $12.9B | $49.9B |
| P/E Ratio | 33.7× | 18.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $112.71 | $272.48 |
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $43.1B | $43.7B | $40.1B | $42.0B | $44.3B |
| JNJ Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |